![John J. Kopchick](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
John J.
Kopchick is the founder of DiAthegen LLC, a company founded in 2001, where he holds the title of Chief Scientific Officer & Principal Investigator.
He is currently working as a Professor at The Ohio University since 1987.
Dr. Kopchick has a graduate and doctorate degree from The University of Texas at Austin, conferred in 1980.
He also has a graduate degree from Indiana University of Pennsylvania, conferred in 1975, and an undergraduate degree from Indiana University of Pennsylvania, conferred in 1972.
Posizioni attive di John J. Kopchick
Società | Posizione | Inizio |
---|---|---|
DiAthegen LLC
![]() DiAthegen LLC Medical SpecialtiesHealth Technology DiAthegen LLC is engaged in biopharmaceutical and diagnostic products. It offers herapeutic targets using genomic and proteomic approaches in animal models obesity, hyperinsulinemea and diabetes. The company was founded by John J. Kopchick and Wolf Vedder in July 2001 and is headquartered in Austin, TX. | Fondatore | 13/04/2010 |
The Ohio University
![]() The Ohio University Other Consumer ServicesConsumer Services Central Hockey League operates a professional minor league hockey teams playing in small to medium-sized markets primarily in central and southwestern US states. The league, which was started in 1992, is managed and operated by WPHL, a subsidiary of Global Entertainment Corporation. | Corporate Officer/Principal | 07/01/2011 |
Formazione di John J. Kopchick
The University of Texas at Austin | Doctorate Degree |
Indiana University of Pennsylvania | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
DiAthegen LLC
![]() DiAthegen LLC Medical SpecialtiesHealth Technology DiAthegen LLC is engaged in biopharmaceutical and diagnostic products. It offers herapeutic targets using genomic and proteomic approaches in animal models obesity, hyperinsulinemea and diabetes. The company was founded by John J. Kopchick and Wolf Vedder in July 2001 and is headquartered in Austin, TX. | Health Technology |
- Borsa valori
- Insiders
- John J. Kopchick